Explore the future of the pharmaceutical industry with this comprehensive report. Delve into key trends via regulatory, clinical, and market analyses. Essential for investors, new entrants, and pharma ...

How AI is reshaping biotech through partnerships, from drug discovery to clinical trials, and what it means for the future of ...

Post-Earnings Positioning: Examine the linkage between immediate and medium-term returns following the earnings release, and ...

BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating initiatives including the integration and disposition of assets acquired in ...

On May 13th, 1980, an F3 tornado traveled 11 miles from the west side of Kalamazoo through downtown before lifting near Comstock. Five people were killed and 79 were seriously injured. Bronson Park, ...

Tris Pharma Inc. can’t be sued by the state of Texas for manipulating test results on medication to treat minors for ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

The FARE Act could save renters thousands of dollars on upfront costs. Meanwhile, there's been some debate on what will ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

Gigamon, a leading deep observability company, today announced it will showcase its Gigamon Deep Observability Pipeline as a sponsor at Cisco Live 2025, June 8-10, at the San Diego Convention Center.

By Michael Erman and Ludwig Burger (Reuters) -Bristol Myers Squibb will pay $1.5 billion upfront to partner with Germany's ...

All three major averages closed out May with sizable gains Friday, with the S&P 500 and Nasdaq Composite seeing their best ...